Skip to main content
Skip to main content
TATYY logo

Tate & Lyle plc (TATYY) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$30.23 -$0.12 (-0.40%) |CouncilBullish Lean · 58 · B
P/E Ratio: 25.11| Vol: 2| Target: $31.70 (estimate, not advice)| 52-wk range: $17.64 – $30.50

P/E 25.11 means the share price is 25.11 times one year of earnings per share; the S&P 500 usually sits near 20-25. Beta 0.35: the stock has moved about 65% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Tate & Lyle plc (TATYY) trades at $30.23. Tate & Lyle plc is a global provider of specialized ingredients and solutions for the food, beverage, and industrial sectors, offering products like texturizers, sweeteners, and health components. Sector: Consumer defensive.

Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026
Tate & Lyle plc is a global provider of specialized ingredients and solutions for the food, beverage, and industrial sectors, offering products like texturizers, sweeteners, and health components. Established in 1903 and headquartered in London, the company operates across three divisions, serving markets including the United States, UK, and continental Europe.

TATYY stock analysis for 2026: The stored analyst price target for Tate & Lyle plc is $31.70; its date is unknown, so no upside or downside is derived from it against the current price of $30.23. Key factors: analyst coverage, company fundamentals.

Watch the TATYY film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 58/100 · B

TATYY: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Neutral read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Tate & Lyle plc (TATYY) Consumer Business Overview

CEOAnthony Nicholas Seymour Hampton
Employees4,840
HeadquartersLondon, GB
IPO Year1996

Tate & Lyle plc is a London-based global ingredient solutions provider for the food, beverage, and industrial sectors, specializing in texturizers, nutritive sweeteners, and health and wellness components. With a diverse product portfolio and operations across the US, UK, and continental Europe, it addresses evolving consumer demands for healthier and functional products.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 14, 2026

What Is the Investment Thesis for TATYY?

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Tate & Lyle plc presents a compelling profile as a specialized ingredient provider with a $7.11 billion market capitalization, driven by its focus on health and wellness solutions. The company's gross margin of 46.9% and profit margin of 4.8% reflect efficient operations within the competitive packaged foods industry. A key value driver is the increasing global demand for healthier food and beverage options, where Tate & Lyle's investments in innovative sweeteners, texturizers, and health components position it favorably. The company's dividend yield of 3.54% offers income potential, while its low Beta of 0.35 suggests lower volatility compared to the broader market. However, the investment thesis must consider the ongoing exposure to commodity price fluctuations, particularly for corn, which can impact profitability. Future growth catalysts include continued innovation in functional ingredients and strategic expansion into emerging markets, while effective management of input costs remains critical for sustained financial performance.

Based on FMP financials and quantitative analysis

TATYY Key Highlights

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Market Capitalization of $7.11 billion, indicating a substantial presence within the global ingredients market.

  • A P/E ratio of 25.11, reflecting investor expectations regarding future earnings potential and growth prospects.
  • Gross Margin of 46.9%, demonstrating strong profitability from the sale of its specialized ingredients and solutions.
  • Profit Margin of 4.8%, showcasing the company's overall operational efficiency in converting revenue into net income.
  • A Dividend Yield of 3.54%, providing a consistent return to shareholders and indicating financial stability.

Who Are TATYY's Competitors?

TATYY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
TSUKF Toyo Suisan Kaisha, Ltd. $65.32 0.00% $6.33B 499-signal
GLAPY Glanbia plc $123.07 0.00% $5.95B
MEJHY Meiji Holdings Co., Ltd. $14.40 0.00% $7.81B 529-signal
EMLZF Emmi AG $1075.00 0.00% $5.75B
NSLYF Nestlé (Malaysia) Berhad $26.49 0.00% $6.21B
NSRGF Nestlé S.A. $95.39 +0.94% $245B 419-signal
DANOY Danone S.A. $14.27 -2.39% $45.8B 449-signal
JBS JBS N.V. $12.62 +0.32% $28.0B 945-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are TATYY's Key Strengths?

Diverse portfolio of specialized ingredients, including health and wellness components, catering to evolving consumer demands.

  • Extensive global footprint with operations across the US, UK, continental Europe, and other international markets.
  • Strong investment in research and development, fostering innovation in ingredient solutions and product applications.
  • Established brand reputation and long operating history since 1903, building trust and reliability with customers.
  • Significant market capitalization of $7.11 billion and a robust gross margin of 46.9%.

What Are TATYY's Weaknesses?

Exposure to volatility in commodity prices, particularly corn, which can impact input costs and profit margins.

  • Reliance on a relatively concentrated customer base of large food and beverage manufacturers.
  • Potential for regulatory changes in food additives and labeling requirements across different jurisdictions.
  • The Sucralose division faces competition from other high-intensity sweeteners and natural alternatives.
  • Profit margin of 4.8% indicates susceptibility to operational cost pressures.

What Could Drive TATYY Stock Higher?

TATYY catalyst: Launch of new, innovative health and wellness ingredient solutions, potentially expanding market share in functional foods.

  • Strategic partnerships aimed at enhancing distribution channels or co-developing novel ingredient technologies, broadening market reach.
  • Publication of annual financial results demonstrating sustained growth in the Food & Beverage Solutions division and effective cost management.
  • Continued investment in R&D leading to patents for new sweeteners or texturizers, strengthening intellectual property.
  • Expansion into new geographic markets, particularly high-growth emerging economies, increasing revenue diversification.

What Are the Key Risks for TATYY?

Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.

  • Volatility in global commodity prices, especially corn, which directly impacts the company's raw material costs and can compress profit margins.
  • Intensified competition from other global ingredient suppliers, leading to pricing pressures and potential erosion of market share.
  • Shifts in consumer preferences or regulatory changes regarding specific food ingredients, such as certain sweeteners or additives, impacting demand for Tate & Lyle's products.
  • Supply chain disruptions due to geopolitical events, adverse weather conditions, or trade policy changes, affecting production and distribution.
  • Adverse currency fluctuations between the British Pound and the U.S. Dollar, impacting the value of ADRs and dividend payouts for U.S. investors.

What Are the Growth Opportunities for TATYY?

  • **Expansion in Health and Wellness Ingredients:** The global market for health and wellness food ingredients is experiencing robust growth, driven by increasing consumer awareness of diet-related health issues and a preference for functional foods. Tate & Lyle's portfolio, including low-calorie sweeteners, dietary fibers, and clean label texturizers, is well-positioned to capitalize on this trend. By continuously innovating and expanding its offerings in this segment, the company can capture a larger share of a market projected to grow significantly over the next decade, enhancing its value proposition to food and beverage manufacturers seeking to reformulate products.
  • **Penetration of Emerging Markets:** As disposable incomes rise and urbanization accelerates in emerging economies across Asia, Latin America, and Africa, there is a growing demand for processed and convenience foods. Tate & Lyle's established global infrastructure and diverse product range, including both specialized and bulk ingredients, enable it to strategically expand its presence in these high-growth regions. By tailoring solutions to local tastes and regulatory environments, the company can unlock substantial new revenue streams and diversify its geographic revenue base over the medium to long term.
  • **Innovation in Sustainable and Plant-Based Solutions:** Consumer and regulatory pressures are driving a shift towards more sustainable and plant-based food systems. Tate & Lyle's expertise in corn-derived ingredients and its R&D capabilities can be leveraged to develop novel plant-based proteins, natural texturizers, and sustainable sourcing practices. Investing in these areas allows the company to meet the demands of environmentally conscious customers and position itself as a leader in sustainable ingredient solutions, potentially opening new market segments and strengthening brand perception within the next five to ten years.
  • **Diversification of Industrial Applications:** While primarily known for food and beverage ingredients, Tate & Lyle also supplies industrial starches for applications in paper, packaging, and adhesives. There is an opportunity to further diversify and expand its offerings within these industrial sectors or explore new non-food applications for its corn-derived products. This diversification can reduce reliance on the food sector's cyclicality, create new revenue streams, and leverage existing production capabilities, providing a stable growth avenue over the long term by tapping into different market dynamics.
  • **Strategic Partnerships and Acquisitions:** To accelerate growth and expand its technological capabilities or market reach, Tate & Lyle can pursue strategic partnerships or targeted acquisitions. Collaborating with innovative startups in biotechnology or acquiring companies with complementary ingredient portfolios could enhance its product offering, gain access to new intellectual property, and strengthen its competitive position. Such strategic moves could lead to faster market penetration in specific high-growth areas or enable the company to offer more integrated solutions to its global customer base within a 3-5 year horizon.

What Threats Does TATYY Face?

  • Intense competition from other global ingredient suppliers, potentially leading to pricing pressures and market share erosion.
  • Significant fluctuations in the cost of raw materials, particularly agricultural commodities, impacting profitability.
  • Rapid shifts in consumer preferences or dietary trends that could diminish demand for certain ingredients.
  • Disruptions in the global supply chain due to geopolitical events, climate change, or pandemics.
  • Introduction of new, disruptive ingredient technologies by competitors or startups.

What Are TATYY's Competitive Advantages?

  • **Extensive R&D Capabilities:** Significant investment in research and development allows for continuous innovation in ingredient science, leading to proprietary formulations and intellectual property in areas like health and wellness.
  • **Global Scale and Distribution Network:** A vast operational footprint across the Americas, Europe, and other international markets, coupled with a robust supply chain, enables efficient delivery and service to a diverse global customer base.
  • **Diverse Product Portfolio:** Offering a wide range of ingredients from texturizers and sweeteners to industrial starches and commodities, reducing reliance on any single product category and catering to varied customer needs.
  • **Deep Customer Relationships and Technical Expertise:** Long-standing relationships with major food and beverage companies, supported by strong technical application teams, make Tate & Lyle an integrated partner rather than just a supplier.
  • **Brand Recognition and Trust:** A long history since 1903 and a strong reputation in the ingredients industry foster trust and reliability among customers, making it a preferred supplier for critical components.

What Does TATYY Do?

Tate & Lyle PLC, established in 1903 and headquartered in London, UK, has evolved into a prominent global provider of specialized ingredients and solutions. The company's extensive operations cater to the food, beverage, and various industrial sectors, maintaining a significant global footprint across the United States, the United Kingdom, continental European countries, and other international markets. Its business is strategically organized into three core divisions: Food & Beverage Solutions, Sucralose, and Primary Products, each contributing to its comprehensive market offering. The Food & Beverage Solutions division focuses on providing a wide array of ingredients such as texturizers, health and wellness components, and stabilizers, which are crucial for enhancing product functionality and meeting consumer preferences for healthier options. The Sucralose division is dedicated to the production and supply of this high-intensity sweetener, addressing the demand for reduced-sugar formulations. The Primary Products division handles nutritive sweeteners like high fructose corn syrup and dextrose, alongside industrial starches utilized in paper, packaging, and adhesives, and acidulants such as citric acid. Beyond these core ingredient offerings, Tate & Lyle also engages in the commodities market, supplying corn gluten feed and meal for animal nutrition, corn oil, and ethanol. The company further diversifies its activities by managing treasury and insurance businesses and investing significantly in research and development services, underscoring its commitment to innovation and adapting to dynamic market needs. This integrated approach allows Tate & Lyle to serve a broad customer base, from multinational food manufacturers to industrial clients, providing essential components that underpin a vast range of consumer and industrial products.

What Products and Services Does TATYY Offer?

  • Develops and supplies specialized ingredients and solutions for the food, beverage, and industrial sectors.
  • Produces and distributes texturizers, which are used to improve the texture and consistency of food products.
  • Offers nutritive sweeteners like high fructose corn syrup and dextrose for various food and beverage applications.
  • Manufactures health and wellness components, including dietary fibers and low-calorie sweeteners such as sucralose.
  • Provides stabilizers that help maintain the physical properties of food and beverage products.
  • Supplies industrial starches for non-food applications like paper, packaging, and adhesives.
  • Produces acidulants, such as citric acid, used to enhance flavor and preserve food.
  • Trades in commodities, including corn gluten feed and meal for animal nutrition, corn oil, and ethanol.

How Does TATYY Make Money?

  • Generates revenue by selling a diverse portfolio of specialized ingredients and solutions to B2B customers globally.
  • Monetizes its R&D capabilities by developing and licensing new ingredient technologies and formulations.
  • Earns income from the production and sale of commodity products derived from corn, such as ethanol and animal feed.
  • Provides value-added services, including technical support and application expertise, to help customers integrate ingredients into their products.
  • Operates treasury and insurance businesses, contributing to overall financial stability and diversification.

What Industry Does TATYY Operate In?

Tate & Lyle plc operates within the Consumer Defensive sector, specifically the Packaged Foods industry, positioning itself as a critical supplier of ingredients rather than a direct consumer brand. The industry is currently shaped by significant trends, including a surging global demand for healthier, functional, and sustainably sourced food and beverage products. Consumers are increasingly seeking low-sugar, high-fiber, and natural ingredient options, which directly aligns with Tate & Lyle's strategic focus on health and wellness components, texturizers, and specialized sweeteners like sucralose. The competitive landscape is characterized by a few large, global ingredient providers, alongside numerous smaller, niche players. Tate & Lyle distinguishes itself through its extensive R&D capabilities, diverse product portfolio, and global distribution network, enabling it to serve multinational food and beverage manufacturers. Its role is to innovate and supply the foundational elements that allow its customers to meet evolving market demands and regulatory standards.

Who Are TATYY's Key Customers?

  • Large multinational food and beverage manufacturers seeking specialized ingredients for product formulation and innovation.
  • Industrial companies in sectors such as paper, packaging, and adhesives that utilize industrial starches and other derivatives.
  • Animal nutrition companies purchasing corn gluten feed and meal for livestock feed formulations.
  • Pharmaceutical and personal care companies, potentially utilizing certain specialized ingredients.
  • Regional food and beverage producers looking for tailored ingredient solutions and technical support.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: Jun 14, 2026

Research confidence

Medium 49/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 164 days ago
  • Covered by analysts
  • Reported in GBP, converted to USD

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 43
2026-08-26 43
2026-08-29 43
2026-09-01 43
2026-09-04 43
2026-09-07 43
2026-09-10 43

What changed?

The score has stayed at 43.

Over the same 18 days the stock moved -0.7%.

Tate & Lyle plc Financial Trajectory

Tate & Lyle plc (TATYY) reported $1.33B in revenue for Q4 FY2026, a decline of 3.9% compared to the prior quarter. The company recorded net income of $55.6M, with diluted EPS of $0.50. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Consumer Defensive. Across the four most recent quarters, TATYY averaged $0.79 in diluted EPS.

Company Profile

Tate & Lyle plc operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in London, GB. The company is led by CEO Anthony Nicholas Seymour Hampton. TATYY has traded publicly since 1996.

ROE 6%

Key Financial Metrics

Return on equity for Tate & Lyle plc stands at 6.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.6%, showing how much profit it generates from its asset base. TATYY trades at a trailing price-to-earnings ratio of 25.11, roughly in line with the Consumer Defensive sector average of ~27.60x. Its free cash flow yield is 5.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.71 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.9%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 4/9

Financial Health

Tate & Lyle plc's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.29 places it in the safe zone, indicating low near-term bankruptcy risk.

3/8 beats

Earnings Track Record

Tate & Lyle plc has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 12.0% below estimates on average.

TATYY Financials

Fundamental Snapshot

Revenue Growth (FY)
+15.6%
Net Income Growth (FY)
-32.2%
EPS Growth (FY)
+83.3%
Free Cash Flow Growth (FY)
+188.3%
P/E (TTM)
25.11
Return on Equity (TTM)
+6.2%
Current Ratio
2.7
EV/EBITDA (TTM)
9.5

Based on FMP financials and quantitative analysis · FY 2026

Bull Case vs Bear Case

Bull Case

  • Diverse portfolio of specialized ingredients, including health and wellness components, catering to evolving consumer demands.
  • Extensive global footprint with operations across the US, UK, continental Europe, and other international markets.
  • Strong investment in research and development, fostering innovation in ingredient solutions and product applications.
  • Established brand reputation and long operating history since 1903, building trust and reliability with customers.

Bear Case

  • Exposure to volatility in commodity prices, particularly corn, which can impact input costs and profit margins.
  • Reliance on a relatively concentrated customer base of large food and beverage manufacturers.
  • Potential for regulatory changes in food additives and labeling requirements across different jurisdictions.
  • The Sucralose division faces competition from other high-intensity sweeteners and natural alternatives.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q4 FY2026 $1.33B $56M $0.50
Q2 FY2026 $1.38B $76M $0.68
Q4 FY2025 $1.01B -$30M -$0.27
Q2 FY2025 $1.05B $223M $2.24

Q4 FY2026 · filed 31 Mar 2026 · Financial Modeling Prep

Based on FMP financials and quantitative analysis · Converted to USD from GBP at today's rate

TATYY Latest News

TATYY Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TATYY.

Price Targets

Consensus target: $31.70

TATYY MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for TATYY; grades run from A+ (80-100) to F (below 30).

Leadership: Anthony Nicholas Seymour Hampton

CEO

Anthony Nicholas Seymour Hampton serves as the Chief Executive Officer of Tate & Lyle plc, overseeing the strategic direction and operational performance of the global ingredients company. His leadership is critical in managing a workforce of 3,318 employees across diverse international markets.

Track Record: Under Anthony Nicholas Seymour Hampton's leadership, Tate & Lyle plc continues to focus on its core strategy of providing specialized ingredients and solutions. Key achievements and strategic decisions under his tenure include sustaining the company's global footprint and driving innovation in health and wellness components. His management aims to enhance shareholder value through strategic investments in R&D and operational efficiencies, particularly in response to market trends for healthier and sustainable food options.

Tate & Lyle plc ADR Information Unsponsored

Tate & Lyle plc trades in the United States as an American Depositary Receipt (ADR), specifically a Level 1 ADR. This mechanism allows U.S. investors to buy shares of a non-U.S. company on U.S. exchanges without having to trade on the company's home stock exchange. For TATYY, this means that while the underlying shares are traded on the London Stock Exchange (LSE) under the ticker TATY, U.S. investors can access them via the over-the-counter (OTC) market in U.S. dollars, simplifying the investment process.

  • Home Market Ticker: London Stock Exchange, United Kingdom
  • ADR Level: 1
  • ADR Ratio: 1:1
  • Home Market Ticker: TATY
Currency Risk: Holders of TATYY ADRs are exposed to currency risk primarily through the exchange rate fluctuations between the British Pound (GBP) and the U.S. Dollar (USD). The value of the ADR, when converted back to the underlying ordinary shares, can be affected by these movements. Furthermore, any dividends declared by Tate & Lyle plc in GBP will be converted to USD before being distributed to ADR holders, meaning the USD value of the dividend can vary depending on the prevailing exchange rate at the time of conversion, impacting the overall return for U.S. investors.
Tax Implications: Dividends paid on TATYY ADRs are typically subject to foreign dividend withholding tax by the UK government. The standard withholding tax rate in the UK is generally 0% for dividends paid to non-residents, but investors should verify their specific tax situation. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for any taxes withheld, depending on the tax treaty between the U.S. and the UK and individual circumstances. Consulting a tax advisor is recommended for specific guidance.
Trading Hours: The underlying shares of Tate & Lyle plc trade on the London Stock Exchange (LSE), which operates from 8:00 AM to 4:30 PM GMT. In contrast, TATYY ADRs trade on the U.S. over-the-counter (OTC) market, which generally aligns with U.S. equity market hours, typically 9:30 AM to 4:00 PM ET. This difference in trading hours means that significant news or price movements in London may not be immediately reflected in the U.S. ADR price until the OTC market opens, potentially leading to price gaps.

TATYY OTC Market Information

TATYY trades on the 'OTC Other' tier of the OTC market, which is the lowest and least regulated tier. Unlike companies listed on major exchanges like NYSE or NASDAQ, or even higher OTC tiers like OTCQX or OTCQB, companies on 'OTC Other' have minimal disclosure requirements. This tier typically includes companies that are not required to or choose not to file financial reports with the SEC, or have fallen out of compliance with higher tiers. For investors, this means less readily available and standardized financial information, increasing the need for independent due diligence compared to more transparent trading venues.

  • OTC Tier: OTC Other
Liquidity: Trading on the OTC Other tier often implies lower liquidity compared to major exchanges. Investors in TATYY may experience wider bid-ask spreads, meaning a larger difference between the price buyers are willing to pay and sellers are willing to accept. This can result in higher transaction costs and difficulty in executing large orders quickly without significantly impacting the stock price. The trading volume might also be lower, making it challenging to enter or exit positions efficiently, particularly for institutional investors.
OTC Risk Factors:
  • **Limited Transparency:** The 'Unknown' disclosure status means less readily available financial and operational information, making it harder for investors to conduct thorough due diligence.
  • **Lower Liquidity:** Trading on the OTC Other tier typically results in lower trading volumes and wider bid-ask spreads, increasing transaction costs and difficulty in executing trades.
  • **Price Volatility:** Limited liquidity and less information can contribute to higher price volatility, as smaller trades can have a disproportionate impact on the stock price.
  • **Less Regulatory Oversight:** OTC Other companies are subject to significantly less regulatory scrutiny than exchange-listed companies, increasing the risk of fraud or misleading information.
  • **Difficulty in Valuation:** The lack of consistent, standardized financial reporting can make it challenging to accurately assess the company's intrinsic value and compare it to peers.
Due Diligence Checklist:
  • Verify the company's financial statements and annual reports directly from its home market (London Stock Exchange filings).
  • Research recent news and press releases from the company and reputable financial news outlets in its home country.
  • Assess the management team's background and track record through independent sources.
  • Understand the company's business model, competitive landscape, and market position in its primary operating regions.
  • Analyze the company's dividend history and policy, considering the ADR structure and currency implications.
  • Evaluate the trading volume and bid-ask spread of the TATYY ADR to understand potential liquidity challenges.
  • Consult with a financial advisor knowledgeable about international and OTC investments.
Legitimacy Signals:
  • **Established History:** Founded in 1903, Tate & Lyle plc has a long operational history, indicating stability and resilience.
  • **Primary Listing on Major Exchange:** The company's ordinary shares are listed on the London Stock Exchange (TATY), a reputable global exchange, suggesting adherence to certain regulatory standards in its home market.
  • **Significant Market Capitalization:** With a market cap of $7.11 billion, it is a substantial and recognized entity in the global ingredients sector.
  • **Global Operations:** Tate & Lyle operates across multiple international markets, including the US, UK, and continental Europe, demonstrating a broad and diversified business presence.
  • **Known CEO:** The company has a publicly known CEO, Anthony Nicholas Seymour Hampton, providing a clear leadership structure.

What Investors Ask About Tate & Lyle plc (TATYY) — Consumer Defensive

Is TATYY a good stock?

Stock Expert AI does not rate TATYY buy, sell or hold. Tate & Lyle plc has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

How does Tate & Lyle plc manage supply chain and input cost risks?

Tate & Lyle plc manages supply chain and input cost risks through a combination of strategic sourcing, operational efficiencies, and hedging strategies.

What are the key factors to evaluate for TATYY?

Evaluate TATYY on fundamentals, analyst consensus, and risk factors. P/E: 25.11x vs the S&P 500's ~20-25x. Tate & Lyle plc presents a compelling profile as a specialized ingredient provider with a $7.11 billion market capitalization, driven by its focus on health and wellness solutions. Not financial advice.

How frequently does TATYY data refresh on this page?

TATYY's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven TATYY's recent stock price performance?

Tate & Lyle plc (TATYY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse portfolio of specialized ingredients, including health and wellness components, catering to evolving consumer demands. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider TATYY overvalued or undervalued right now?

Tate & Lyle plc (TATYY) trades at 25.11x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of TATYY?

Yes, most major brokerages offer fractional shares of Tate & Lyle plc (TATYY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track TATYY's earnings and financial reports?

Tate & Lyle plc (TATYY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for TATYY earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • CEO's background and track record details are limited in the provided source data, leading to general statements.
  • Specific details for ADR tax implications and trading hours differences are generalized based on typical ADR characteristics.
  • OTC disclosure status is explicitly stated as 'Unknown' in the source, which is reflected in the analysis.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover